Skip to main content

Table 2 Clinical characteristics analysis for progression-free survival and overall survival

From: MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy

Characteristics

Progression-free survival

Overall survival

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

HR (95% CI)

P-value

HR (95% CI)

P-value

HR(95% CI)

P-value

HR (95% CI)

P-value

Age

0.972(0.942, 1.002)

0.069

  

0.994(0.950, 1.041)

0.807

  

BMI

0.954(0.877, 1.037)

0.265

  

1.003(0.895, 1.124)

0.960

  

SCC

1.001(0.990, 1.012)

0.875

  

1.008(0.995, 1.021)

0.231

  

Tumor grade

1.327(0.744, 2.366)

0.338

  

2.220(1.013, 4.867)

0.046

  

T stage

2.934(1.952, 4410)

<0.001

1.849(1.116, 3.063)

0.017

3.332(1.897, 5.589)

<0.001

2.409(1.161, 5.002)

0.018

Tumor maximum diameter

1.508(1.178, 1.930)

0.001

1.206(0.923, 1.577)

0.170

1.610(1.171, 2.214)

0.003

  

LNM position

2.476(1.666, 3.679)

<0.001

1.678(1.049, 2.684)

0.031

2.606(1.555, 4.366)

<0.001

1.521(0.758, 3.054)

0.238

LNM number

1.910(1.377, 2.650)

<0.001

  

2.054(1.298, 3.252)

0.002

  
  1. BMI Body mass index, SCC-Ag Serum levels of squamous cell carcinoma antigen, LNM Lymph node metastasis.
Back to article page